Latest filing published 26 Aug 2025 for LifeMD, Inc..
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Stefan Galluppi in LifeMD, Inc., where the filings describe the role as senior executive. Between 25 April 2019 and 22 August 2025, the trades on record add up to 18 filings.
Market trades split into 10 purchases (€93k) and 2 sales (€1.3M). Netting one side against the other leaves €1.2M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 6 share grants. Since January 2025: no purchases and 1 sale on the market.
Half of the purchases are above €6,726 and half below. Of 10 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 26 August 2025 with a share grant in LifeMD, Inc. The clock since the last published purchase (12 September 2024) now reads 772 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 of 12 declarations